Genpact Ltd (NYSE:G) price on current trading day, rose 11.08% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $54.87.
A look at the stock’s price movement, the level at last check in today’s session was $49.40, moving within a range at $54.8 and $56.755. The beta value (5-Year monthly) was 1.141 while the PE ratio in trailing twelve months stood at 15.05. Turning to its 52-week performance, $49.68 and $30.23 were the 52-week high and 52-week low respectively. Overall, G moved 27.97% over the past month.
Genpact Ltd’s market cap currently stands at around $9.68 billion, with investors looking forward to this quarter’s earnings report slated for in March. The company has a Forward Dividend ratio of 0.61, with its dividend yield at 1.11%. As such, investors might be keen on an upside in the stock’s price ahead of the scheduled earnings report.
Analysts have a consensus estimate of 1.21B for the company’s revenue for the quarter, with a low and high estimate of 1.2B and 1.21B respectively. The average forecast suggests up to a 6.77% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 5.07B, representing a 6.43% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that G is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
6 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 5 analyst(s) rate the stock as a Hold, 1 recommend G as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Hold which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
The technical evaluation for the stock shows the PEG ratio is 1.53, with G’s current price about 16.59% and 21.05% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 90.94, while 7-day volatility ratio is 1.79% and 2.04% in the 30-day chart. Further, Genpact Ltd (G) has a beta value of 1.19, and an average true range (ATR) of 1.37. Analysts have given the company’s stock an average 52-week price target of $44, forecast between a low of $42 and high of $45. Looking at the price targets, the low is 23.46% off recent price level in today’s trading while to achieve the yearly target high, it has to move 17.99%. Nonetheless, investors will most likely welcome a 19.81% jump to $44 which is the analysts’ median price.
If we refocus on Genpact Ltd (NYSE:G), historical trading data shows that trading volumes averaged 1.58 over the past 10 days and 1.50 million over the past 3 months. The company’s latest data on shares outstanding shows there are 176.35 million shares.
The 8.33% of Genpact Ltd’s shares are in the hands of company insiders while institutional holders own 95.61% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 5.29 million on 2025-01-15, giving us a short ratio of 3.77. The data shows that as of 2025-01-15 short interest in Genpact Ltd (G) stood at 392.0 of shares outstanding, with shares short falling to 5.51 million registered in 2024-12-13. Current price change has pushed the stock 27.76% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the G stock continues to rise going into the next quarter.
